Benjamin Besse

Benjamin Besse

UNVERIFIED PROFILE

Are you Benjamin Besse?   Register this Author

Register author
Benjamin Besse

Benjamin Besse

Publications by authors named "Benjamin Besse"

Are you Benjamin Besse?   Register this Author

100Publications

1486Reads

31Profile Views

Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm.

Nat Rev Clin Oncol 2020 Jul 7. Epub 2020 Jul 7.

Department of Medicine, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-020-0399-6DOI Listing
July 2020

Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung Cancer.

JAMA Oncol 2020 Jun 11. Epub 2020 Jun 11.

UMR (Unité Mixte de Recherche) 1281, Université Paris-Saclay, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Commissariat à l'énergie Atomique et Aux Énergies Alternatives, Laboratoire d'Imagerie Biomédicale Multimodale Paris-Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2020.1634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290708PMC
June 2020

IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment.

J Immunother Cancer 2020 Jun;8(1)

Analyse Moléculaire, Modélisation et Imagerie de la Maladie Cancéreuse, Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy Institute, INSERM, CNRS, Paris-Saclay University, Villejuif, Île-de-France, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jitc-2020-000632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295443PMC
June 2020

The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study.

Eur J Cancer 2020 May 12;130:39-50. Epub 2020 Mar 12.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne and Immunologie clinique, Le Kremlin-Bicêtre, France; INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin Bicêtre, France; Université Paris Sud, UMR 1184, Le Kremlin Bicêtre, France; CEA, DSV/iMETI, IDMIT, Fontenay-aux-Roses, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.02.010DOI Listing
May 2020

Current panorama and challenges for neoadjuvant cancer immunotherapy.

Clin Cancer Res 2020 May 20. Epub 2020 May 20.

Medical Oncology, Institut Gustave Roussy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-3255DOI Listing
May 2020

Cystic brain metastases and fusion in lung cancer.

Transl Lung Cancer Res 2020 Apr;9(2):424-425

Department of Medicine and Surgery, University of Parma, Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2020.02.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225137PMC
April 2020

Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 cases.

Ann Diagn Pathol 2020 Apr 20;46:151522. Epub 2020 Apr 20.

Department of Pathology, Marie Lannelongue Hospital, 133 avenue de la Résistance, 92350 Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anndiagpath.2020.151522DOI Listing
April 2020

Systemic lupus erythematosus associated with thymoma: A fifteen-year observational study in France.

Autoimmun Rev 2020 Mar 7;19(3):102464. Epub 2020 Jan 7.

Assistance Publique - Hôpitaux de Paris, Hopital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275 Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276 Le Kremlin-Bicêtre, France; INSERM, U1184, Immunologie des Maladies Virales et Autoimmunes, F-94276 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, Département d'Immunovirologie, IDMIT, F-92265 Fontenay-aux-Roses, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2020.102464DOI Listing
March 2020

Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?

Clin Cancer Res 2020 Feb 22;26(4):787-792. Epub 2019 Nov 22.

Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-2337DOI Listing
February 2020

Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter?

Lung Cancer 2020 01 13;139:216-218. Epub 2019 Nov 13.

Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.11.005DOI Listing
January 2020

Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.

J Thorac Oncol 2019 12 11;14(12):2053-2061. Epub 2019 Jun 11.

Department of Intensive Care and Oncological Emergencies and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.037DOI Listing
December 2019

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.

Eur J Cancer 2019 12 23;123:28-35. Epub 2019 Oct 23.

Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.09.013DOI Listing
December 2019

One or Two Immune Checkpoint Inhibitors?

Cancer Cell 2019 Dec;36(6):579-581

Department of Cancer Medicine, Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France; Paris-Saclay university, 63 Rue Gabriel Péri, 94270 Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.11.005DOI Listing
December 2019

CheckMate 153 study: are age and performance status relevant for immune checkpoint inhibitor efficacy?

Transl Lung Cancer Res 2019 Dec;8(Suppl 4):S464-S467

Gustave Roussy, Department of Cancer Medicine, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2019.12.26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987362PMC
December 2019

In Response to the Letter by Dr. Yang et al, Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Forcing on Organ-Specific irAEs and the Critical Role of Steroids.

J Thorac Oncol 2019 11;14(11):e260-e261

Medical Oncology Department, Centro Integral Oncología Clara Campal Bacelona, HM-Delfos, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.07.029DOI Listing
November 2019

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

Eur J Cancer 2019 11 28;122:109-114. Epub 2019 Oct 28.

Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.09.012DOI Listing
November 2019

Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC.

J Thorac Oncol 2019 10 11;14(10):e215-e216. Epub 2019 Jul 11.

Cancer Medicine Department, Gustave Roussy, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.07.001DOI Listing
October 2019

Treatment duration of checkpoint inhibitors for NSCLC.

Lancet Respir Med 2019 10 7;7(10):835-837. Epub 2019 Aug 7.

Gustave Roussy, Department of Cancer Medicine, 94805 Villejuif, France; Université Paris-Saclay, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30192-4DOI Listing
October 2019

Is There Room for Immune Checkpoint Inhibitors in Patients Who Have NSCLC With Autoimmune Diseases?

J Thorac Oncol 2019 10 13;14(10):1701-1703. Epub 2019 Aug 13.

Gustave Roussy, Department of Cancer Medicine, Villejuif, France; Université Paris-Saclay, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.07.004DOI Listing
October 2019

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Lung Cancer 2019 10 13;136:145-147. Epub 2019 Aug 13.

The University of Manchester, Division of Cancer Sciences, The Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.007DOI Listing
October 2019

Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?

Immunotherapy 2019 09 30;11(13):1149-1160. Epub 2019 Jul 30.

Department of Cancer Medicine, Gustave Roussy Institute, F-94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2019-0071DOI Listing
September 2019

Letter to the Editor about Sorich et al.

J Thorac Oncol 2019 09;14(9):e209

Cancer Medicine Department, Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.022DOI Listing
September 2019

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.

Eur J Cancer 2019 07 13;116:182-189. Epub 2019 Jun 13.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.019DOI Listing
July 2019

Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?

J Thorac Oncol 2019 06 23;14(6):963-967. Epub 2019 Apr 23.

Gustave Roussy, Cancer Medicine Department, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.031DOI Listing
June 2019

Multiple colic intussusceptions.

Clin Case Rep 2019 Jun 11;7(6):1265-1266. Epub 2019 May 11.

Department of Oncologic Digestive Surgery Gustave Roussy Institute Villejuif France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.2181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552947PMC
June 2019

Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer-In Reply.

JAMA Oncol 2019 05;5(5):744

Department of Cancer Medicine, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.0138DOI Listing
May 2019

Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?

Eur J Cancer 2019 05 6;113:28-31. Epub 2019 Apr 6.

Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, F-94805, France; CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud Univ., Villejuif France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049193018
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2019.02.016DOI Listing
May 2019

Exploring the optimal use of alectinib.

Lancet Respir Med 2019 05 15;7(5):373-374. Epub 2019 Apr 15.

Cancer Medicine Department, Gustave Roussy Cancer Center, F-94805, Villejuif, France; University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30117-1DOI Listing
May 2019

Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean?

J Thorac Oncol 2019 03;14(3):328-331

Medical School, Paris-Saclay University, Paris-Sud University, Le Kremlin Bicêtre, France; Drug Development Department (DITEP), Gustave Roussy Institute, Paris Saclay University, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.12.011DOI Listing
March 2019

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Lancet Haematol 2019 Jan 4;6(1):e48-e57. Epub 2018 Dec 4.

Service de Médecine Interne and Immunologie Clinique, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France; Université Paris Sud, Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-Immunes, INSERM, Le Kremlin-Bicêtre, France; Division d'Immunovirologie, Commissariat à l'Energie Atomique et aux Energies Alternatives, Fontenay-aux-Roses, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30175-3DOI Listing
January 2019

Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer.

Eur J Cancer 2019 01 5;106:144-159. Epub 2018 Dec 5.

Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Medical Oncology, Manchester University NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183145
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.11.002DOI Listing
January 2019

Hyperprogressive disease: recognizing a novel pattern to improve patient management.

Nat Rev Clin Oncol 2018 12;15(12):748-762

Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41571-018-0111-2
Publisher Site
http://dx.doi.org/10.1038/s41571-018-0111-2DOI Listing
December 2018

Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy.

Transl Lung Cancer Res 2018 Dec;7(6):647-660

Department of Cancer Medicine, Gustave Roussy, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://tlcr.amegroups.com/article/view/24555/18844
Publisher Site
http://dx.doi.org/10.21037/tlcr.2018.09.22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249615PMC
December 2018

Prolonged Leptomeningeal Responses with Brigatinib in Two Heavily Pretreated ALK-Rearranged Non-Small Cell Lung Cancer Patients.

J Thorac Oncol 2018 11 6;13(11):e215-e217. Epub 2018 Jun 6.

Medical Oncology Department, Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.033DOI Listing
November 2018

Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?

Nat Rev Clin Oncol 2018 11;15(11):694-708

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0081-4DOI Listing
November 2018

Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy.

Int J Clin Pharm 2018 Oct 9;40(5):1265-1271. Epub 2018 May 9.

Department of Medical Oncology, Gustave Roussy Cancer Campus, 114 rue Edouard-Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11096-018-0649-1
Publisher Site
http://dx.doi.org/10.1007/s11096-018-0649-1DOI Listing
October 2018

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 10 20;36(28):2872-2878. Epub 2018 Aug 20.

Matthew D. Hellmann, Parker Institute for Cancer Immunotherapy; Kathryn C. Arbour, Niamh Long, Hira Rizvi, Andy Ni, W. Victoria Lai, Joshua K. Sabari, Andrew J. Plodkowski, Darragh Halpenny, Jamie E. Chaft, Gregory J. Riely, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Kathryn C. Arbour, W. Victoria Lai, Joshua K. Sabari, Jamie E. Chaft, Gregory J. Riely, and Matthew D. Hellmann, Weill Cornell Medical College, New York, NY; Laura Mezquita, Roberto Ferrara, Lizza E.L. Hendriks, Caroline Caramella, Benjamin Besse, and David Planchard, Gustave Roussy Cancer Center, Villejuif; Edouard Auclin, Hôpital Européen Georges Pompidou; Benjamin Besse, Paris-Sud University, Le Kremlin Bicêtre, Paris, France; Gala Martínez-Bernal, Virgen del Rocío Hospital, Seville, Spain; Lizza E.L. Hendriks, Maastricht University Medical Center, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.0006DOI Listing
October 2018

Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer.

Lung Cancer 2018 09 27;123:14-21. Epub 2018 Apr 27.

Aix Marseille University, Jardin du Pharo, 58, bd Charles Livon, 13284 Marseille, France; Assistance Publique Hôpitaux de Marseille, 80, rue Brochier, 13005 Marseille, France; Centre d'Essais Précoces en Cancérologie de Marseille (CLIP(2)), Hôpital La Timone - Basement F, 1st Floor, 264, rue St Pierre, 13885 Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.04.022DOI Listing
September 2018

Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment.

Cancer Treat Rev 2018 Jul 31;68:69-79. Epub 2018 May 31.

Department of Cancer Medicine, Gustave Roussy, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, F-94805 Villejuif, France; Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.05.015DOI Listing
July 2018

Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?

J Surg Oncol 2018 Jun 24;117(7):1570-1574. Epub 2018 Mar 24.

Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Paris Sud University, Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25042DOI Listing
June 2018

Do immune checkpoint inhibitors need new studies methodology?

J Thorac Dis 2018 May;10(Suppl 13):S1564-S1580

U.O.C. Oncology, University of Verona, Comprehensive Cancer Center, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.01.131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994495PMC
May 2018

Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment.

Front Oncol 2018 11;8:88. Epub 2018 Apr 11.

Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904204PMC
April 2018

Progress in the Management of Advanced Thoracic Malignancies in 2017.

J Thorac Oncol 2018 03 11;13(3):301-322. Epub 2018 Jan 11.

Medical Oncology Department, Gustave Roussy, Villejuif, France; Cancer Medicine Department, University Paris-Saclay, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183000
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.01.002DOI Listing
March 2018

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease.

Eur J Cancer 2018 03 10;91:21-29. Epub 2018 Jan 10.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275, Le Kremlin-Bicêtre, France; INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, F-94276, Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276, Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, IDMIT, F-92265, Fontenay-aux-Roses, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.008DOI Listing
March 2018

Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.

Lung Cancer 2017 10 29;112:10-15. Epub 2017 Jul 29.

Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.004DOI Listing
October 2017

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.

Lung Cancer 2017 10 7;112:62-68. Epub 2017 Aug 7.

Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.002DOI Listing
October 2017